Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patient in Routine Clinical Practice.

Document Type

Article

Publication Date

4-19-2019

Publication Title

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical Institute

Cancer

Department

Oncology

Share

COinS